Blog
-
-
Another CAR-T Impresses in Follicular Lymphoma
-
World’s first blood test for real-time monitoring of cancer treatment success
-
An AstraZeneca, Merck drug slows the return of genetic breast cancer. Will testing speed up?
-
J&J’s new cancer drug leads a growing pipeline of dual-targeting antibodies
-
CMS again delays breakthrough device payment rule in nod to skeptics
-
Sandoz’s Enbrel biosim case turned away at SCOTUS, giving Amgen’s blockbuster 8 more years of free rein
-
PRESS RELEASE: AMS Accelerates Growth with Key Executive Hire
-
AIDS virus used in gene therapy to fix ‘bubble baby’ disease
-
Another 5 years of dominance: Oncology, immunology will extend their lead as pharma’s top fields through 2025